Helena Cortez-Pinto

25PUBLICATIONS
122CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedLiquid biopsiesPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Apr 04, 2026
Transmural improvement may be an acceptable target in patients with Crohns disease.

Samuel Raimundo Fernandes, Sérgio Bronze, Inês Coelho Rodrigues

|Mar 02, 2025
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.

Francisco Capinha, Sofia Carvalhana, Helena Cortez-Pinto

|Jun 07, 2024
Shaping new paths in clinical trial design to address alcohol use disorders and alcohol-associated liver disease.

Juliana Serrazina, Helena Cortez-Pinto

|May 16, 2024
The degree of bowel remission predicts phenotype progression in Crohn's disease.

Samuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva

|Dec 19, 2023
Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis.

Vlad Ratziu, Sven Francque, Cynthia A Behling

|Dec 14, 2023
Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease.

Samuel Raimundo Fernandes, Sónia Bernardo, Sofia Saraiva

Pageof 5